Home > Investors > SEC Section 16 Reports

SEC Section 16 Reports

BOARD MEMBERS

 

Brian A. Markison
President and Chief Executive Officer and Chairman of the Board
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/18/2007 Form Type 4
  3/23/2007 Form Type 4
  2/28/2007 Form Type 4
  3/22/2006 Form Type 4
  10/20/2005 Form Type 4
  7/16/2004 Form Type 4
  3/9/2004 Form Type 4
  3/9/2004 Form Type 3
 

Joseph  Squicciarino
Chief Financial Officer
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/18/2007 Form Type 4
  7/6/2007 Form Type 4
  5/17/2007 Form Type 4
  3/23/2007 Form Type 4
  2/28/2007 Form Type 4
  10/4/2006 Form Type 4
  3/22/2006 Form Type 4
  10/20/2005 Form Type 4
  7/6/2005 Form Type 3
 

James W. Elrod
General Counsel and Secretary
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/3/2007 Form Type 4
  3/23/2007 Form Type 4
  2/28/2007 Form Type 4
  3/22/2006 Form Type 4
  3/3/2006 Form Type 3
 

Frederick  Brouillette, Jr.
Corporate Compliance Officer
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/18/2007 Form Type 4
  3/23/2007 Form Type 4
  2/28/2007 Form Type 4
  3/22/2006 Form Type 4
  10/20/2005 Form Type 4
  3/17/2004 Form Type 4
  8/8/2003 Form Type 3
 

Stephen J. Andrzejewski
Chief Commercial Operations Officer
  6/5/2008 Form Type 4
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/18/2007 Form Type 4
  5/17/2007 Form Type 4
  3/23/2007 Form Type 4
  2/28/2007 Form Type 4
  3/22/2006 Form Type 4
  10/20/2005 Form Type 4
  3/25/2005 Form Type 3
 

Eric G. Carter
Chief Science Officer
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/3/2007 Form Type 4
  3/23/2007 Form Type 4
  2/26/2007 Form Type 4
  2/26/2007 Form Type 3
 

James E. Green
Executive Vice President, Corporate Affairs
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/18/2007 Form Type 4
  3/23/2007 Form Type 4
  2/28/2007 Form Type 4
  3/22/2006 Form Type 4
  10/20/2005 Form Type 4
  3/29/2005 Form Type 3
 

Eric J. Bruce
Chief Technical Operations Officer
  3/27/2008 Form Type 4
  2/22/2008 Form Type 4
  12/18/2007 Form Type 4
  3/23/2007 Form Type 4
  2/28/2007 Form Type 4
  3/22/2006 Form Type 4
  10/20/2005 Form Type 4
  6/21/2005 Form Type 3
 

Ted G. Wood
Lead Independent Director
  5/19/2008 Form Type 4
  5/2/2007 Form Type 4
  10/4/2006 Form Type 4
  5/2/2006 Form Type 4
  5/2/2005 Form Type 4
  5/3/2004 Form Type 4
  3/17/2004 Form Type 4
  2/5/2004 Form Type 5
  9/3/2003 Form Type 3
 

Earnest W. Deavenport, Jr.
Director
  5/19/2008 Form Type 4
  5/2/2007 Form Type 4
  10/4/2006 Form Type 4
  5/2/2006 Form Type 4
  5/3/2005 Form Type 4
  5/2/2005 Form Type 4
  8/6/2003 Form Type 4
 

Elizabeth M. Greetham
Director
  5/19/2008 Form Type 4
  5/2/2007 Form Type 4
  10/4/2006 Form Type 4
  5/2/2006 Form Type 4
  5/2/2005 Form Type 4
  5/3/2004 Form Type 4
  3/17/2004 Form Type 4
  2/17/2004 Form Type 3
 

Philip A. Incarnati
Director
  5/19/2008 Form Type 4
  5/2/2007 Form Type 4
  11/3/2006 Form Type 4
  11/3/2006 Form Type 3
 

Gregory D. Jordan
Director
  5/19/2008 Form Type 4
  5/2/2007 Form Type 4
  10/4/2006 Form Type 4
  5/2/2006 Form Type 4
  5/2/2005 Form Type 4
  5/3/2004 Form Type 4
  8/6/2003 Form Type 4
 

R. Charles Moyer
Director
  5/19/2008 Form Type 4
  5/5/2008 Form Type 4
  9/5/2007 Form Type 4
  5/2/2007 Form Type 4
  10/4/2006 Form Type 4
  5/18/2005 Form Type 4
  5/3/2004 Form Type 4
  8/6/2003 Form Type 4
 

D. Greg Rooker
Director
  5/19/2008 Form Type 4
  4/10/2008 Form Type 4
  2/14/2008 Form Type 5
  5/2/2007 Form Type 4
  2/14/2007 Form Type 4
  1/18/2007 Form Type 4
  10/4/2006 Form Type 4
  5/2/2006 Form Type 4
  1/19/2006 Form Type 4
  12/21/2005 Form Type 4
  5/2/2005 Form Type 4
  2/14/2005 Form Type 5
  12/14/2004 Form Type 4
  5/3/2004 Form Type 4
  2/17/2004 Form Type 5/A
  2/13/2004 Form Type 5
  2/13/2004 Form Type 4
  8/6/2003 Form Type 4
 

Philip M. Pfeffer
Former Director
  5/2/2006 Form Type 4
  5/2/2005 Form Type 4
  5/3/2004 Form Type 4
  8/6/2003 Form Type 4
.

INFORMATION

These links will retrieve copies of Section 16 reports (Forms 3, 4 and 5) that the directors and executive officers of King Pharmaceuticals, Inc. (King) have filed with the United States Securities and Exchange Commission's EDGAR system on or after July 1, 2003.

A complete list of these Section 16 filings is available. Also available is a list of filings that King has made with the SEC.

Please call (423) 989-8711 with questions, comments, or requests for additional information.


page photo